Absorption |
Blood-Brain Barrier | BBB+ | 0.9890 |
Human Intestinal Absorption | HIA+ | 0.9934 |
Caco-2 Permeability | Caco2+ | 0.7329 |
P-glycoprotein Substrate | Substrate | 0.8872 |
P-glycoprotein Inhibitor | Inhibitor | 0.9060 |
Inhibitor | 0.5000 |
Renal Organic Cation Transporter | Inhibitor | 0.6701 |
Distribution |
Subcellular localization | Plasma membrane | 0.4241 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8326 |
CYP450 2D6 Substrate | Substrate | 0.6581 |
CYP450 3A4 Substrate | Non-substrate | 0.5000 |
CYP450 1A2 Inhibitor | Inhibitor | 0.7998 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8897 |
CYP450 2D6 Inhibitor | Inhibitor | 0.9111 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.7202 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.7461 |
CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.5400 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8688 |
Inhibitor | 0.7855 |
AMES Toxicity | Non AMES toxic | 0.8588 |
Carcinogens | Non-carcinogens | 0.9160 |
Fish Toxicity | High FHMT | 0.8578 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9189 |
Honey Bee Toxicity | Low HBT | 0.7827 |
Biodegradation | Not ready biodegradable | 0.9973 |
Acute Oral Toxicity | III | 0.7708 |
Carcinogenicity (Three-class) | Non-required | 0.7563 |